Cargando…

Economic benefits of the United States’ AIDS drug assistance Program: A systematic review of cost analyses to guide research and policy priorities

As part of the Ryan White HIV/AIDs Program, the federally-funded, state-administered AIDS Drug Assistance Program (ADAP) provides prescription drug medications, including antiretroviral therapy, for people with HIV (PWH) who are uninsured/underinsured and have a low income. ADAP expenditures are ∼$2...

Descripción completa

Detalles Bibliográficos
Autores principales:	McManus, Kathleen A., Strumpf, Andrew, Killelea, Amy, Horn, Tim, Hamp, Auntré, Keim-Malpass, Jessica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502648/ https://www.ncbi.nlm.nih.gov/pubmed/36161113 http://dx.doi.org/10.1016/j.pmedr.2022.101969

Ejemplares similares

Ryan White HIV/AIDS Part B and AIDS Drug Assistance Programs during COVID-19: safety net public health programs’ challenges and innovations
por: McManus, Kathleen A., et al.
Publicado: (2023)

Access to a novel first-line single-tablet HIV antiretroviral regimen in Affordable Care Act Marketplace plans, 2018–2020
por: Khazanchi, Rohan, et al.
Publicado: (2023)

Assisters Succeed in Insurance Navigation for People Living with HIV and People at Increased Risk of HIV in a Complex Coverage Landscape
por: McManus, Kathleen A., et al.
Publicado: (2020)

Access to Medications for Opioid Use Disorder for Persons With Human Immunodeficiency Virus in the United States: Gaps in Coverage by State AIDS Drug Assistance Programs
por: McManus, Kathleen A, et al.
Publicado: (2022)

Geographic Variation in Qualified Health Plan Coverage and Prior Authorization Requirements for HIV Preexposure Prophylaxis
por: McManus, Kathleen A., et al.
Publicado: (2023)

Worsening Disparities in State-Level Uptake of Human Immunodeficiency Virus Preexposure Prophylaxis, 2014–2018
por: Powers, Samuel D, et al.
Publicado: (2021)

Effects of recent Virginia AIDS Drug Assistance Program policy changes on diabetes and hyperlipidemia control in people living with HIV
por: McManus, Kathleen A, et al.
Publicado: (2014)

870. Coverage, Cost Sharing, and Out-of-Pocket Costs for Single-Tablet HIV Antiretroviral Regimens in Qualified Health Plans in the United States, 2018-2020
por: Khazanchi, Rohan, et al.
Publicado: (2021)

Cost Utility of Bronchial Thermoplasty for Severe Asthma: Implications for Future Cost-Effectiveness Analyses Based on Phenotypic Heterogeneity
por: Keim-Malpass, Jessica, et al.
Publicado: (2022)

Patient Perspective of People with HIV Who Gained Medicaid Through Medicaid Expansion: A Cross-Sectional Qualitative Study
por: McManus, Kathleen A., et al.
Publicado: (2022)

883. The Current State of Access: Inequitable Access to Infectious Disease Physicians in the Time of the COVID-19 Pandemic and Declining Fellowship Match Rates
por: Fuller, Benjamin P, et al.
Publicado: (2023)

Cross-Jurisdictional Data Exchange Impact on the Estimation of the HIV Population Living in the District of Columbia: Evaluation Study
por: Hamp, Auntre D, et al.
Publicado: (2018)

Regional Disparities in Qualified Health Plans’ Prior Authorization Requirements for HIV Pre-exposure Prophylaxis in the United States
por: McManus, Kathleen A., et al.
Publicado: (2020)

UNOS policy change benefits high‐priority patients without harming those at low priority
por: Wolfson, Aaron M., et al.
Publicado: (2022)

Health literacy and the Affordable Care Act: a policy analysis for children with special health care needs in the USA
por: Keim-Malpass, Jessica, et al.
Publicado: (2015)

Current Challenges to the United States' AIDS Drug Assistance Program and Possible Implications of the Affordable Care Act
por: McManus, Kathleen A., et al.
Publicado: (2013)

The economics of medicines optimization: policy developments, remaining challenges and research priorities
por: Faria, Rita, et al.
Publicado: (2014)

Measuring the Benefits of Decision Aids for Economic Evaluation
por: Butt, Thomas
Publicado: (2018)

Geographic Accessibility of COVID-19 Test to Treat Sites by Race, Ethnicity, Age, and Rurality
por: Khazanchi, Rohan, et al.
Publicado: (2022)

Affordable Care Act Qualified Health Plan Enrollment for AIDS Drug Assistance Program Clients: Virginia's Experience and Best Practices
por: McManus, Kathleen A., et al.
Publicado: (2016)

An economic examination of private insurance claims among adolescents and young adults who were enrolled in hospice during the last year of life
por: Keim-Malpass, Jessica, et al.
Publicado: (2018)

Economic Aspects of Delivering Primary Care Services: An Evidence Synthesis to Inform Policy and Research Priorities
por: CLARKE, LORCAN, et al.
Publicado: (2021)

Telerehabilitation Policy Report: Interprofessional Policy Principles and Priorities
por: Terrell, Evelyn Abrahante, et al.
Publicado: (2021)

Emission Reduction Benefits and Economic Benefits of China's Pilot Policy on Carbon Emission Trading System
por: Wang, Zhijia, et al.
Publicado: (2022)

Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy
por: Keim-Malpass, Jessica, et al.
Publicado: (2017)

Science and technology policy: priorities of governments
por: Tisdell, C A
Publicado: (1981)

Health Policy Priorities for the Biden Administration
por: Japinga, Mark, et al.
Publicado: (2022)

Facilitators and Barriers: Clients' Perspective on the Virginia AIDS Drug Assistance Program's Affordable Care Act Implementation
por: McManus, Kathleen A., et al.
Publicado: (2019)

Research priorities in the field of HIV and AIDS in Iran
por: Haghdoost, AliAkbar, et al.
Publicado: (2012)

State Level Point-of-Sale Policy Priority as a Result of the FSPTCA
por: Moreland-Russell, Sarah, et al.
Publicado: (2015)

Association of Age at Cancer Diagnosis and Clinical Trial Participation
por: Keim-Malpass, Jessica, et al.
Publicado: (2021)

Nursing and precision predictive analytics monitoring in the acute and intensive care setting: An emerging role for responding to COVID-19 and beyond
por: Keim-Malpass, Jessica, et al.
Publicado: (2021)

Research priorities for pregnancy hypertension: a UK priority setting partnership with the James Lind Alliance
por: Ho, Alison, et al.
Publicado: (2020)

Year 2 of Affordable Care Act Qualified Health Plans (QHPs) in a Medicaid Nonexpansion State: QHPs Associated With Viral Suppression for Virginia AIDS Drug Assistance Program Clients
por: McManus, Kathleen A, et al.
Publicado: (2018)

Priority setting and health policy and systems research
por: Ranson, Michael K, et al.
Publicado: (2009)

Policies and priorities to combat NCD challenges in India
por: Sogarwal, Ruchi, et al.
Publicado: (2014)

Understanding economic evidence for the prevention and treatment of atopic eczema
por: Sach, T.H., et al.
Publicado: (2019)

AIDS campaign signals new WHO priorities and approach
por: Kapp, Clare
Publicado: (2003)

Financial, Food, and Housing Insecurity Due to Coronavirus Disease 2019 Among At-Risk People With Human Immunodeficiency Virus in a Nonurban Ryan White HIV/AIDS Program Clinic
por: Sherbuk, Jacqueline E, et al.
Publicado: (2020)

A Dynamic Approach to Economic Priority Setting to Invest in Youth Mental Health and Guide Local Implementation: Economic Protocol for Eight System Dynamics Policy Models
por: Lawson, Kenny D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mkcgm3sb1eqfulk1qpnbri6hjs